|
LARP1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.55429999374002E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.5307999996822E-07 |
| Normal-vs-Stage2 |
2.33019999962281E-07 |
| Normal-vs-Stage3 |
8.08500000282208E-08 |
| Normal-vs-Stage4 |
8.28489999937787E-08 |
| Stage1-vs-Stage2 |
4.713600E-02 |
| Stage1-vs-Stage3 |
1.316380E-01 |
| Stage1-vs-Stage4 |
4.669500E-02 |
| Stage2-vs-Stage3 |
4.183000E-01 |
| Stage2-vs-Stage4 |
9.543400E-01 |
| Stage3-vs-Stage4 |
4.338200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20929999347652E-09 |
| Normal-vs-AfricanAmerican |
1.039560E-03 |
| Normal-vs-Asian |
1.71681999999729E-05 |
| Caucasian-vs-AfricanAmerican |
8.843000E-01 |
| Caucasian-vs-Asian |
6.745800E-01 |
| AfricanAmerican-vs-Asian |
7.026200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55860000017327E-07 |
| Normal-vs-Female |
9.15959996738991E-09 |
| Male-vs-Female |
9.790600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.64479999999312E-05 |
| Normal-vs-Age(41-60Yrs) |
3.6375003009681E-10 |
| Normal-vs-Age(61-80Yrs) |
4.87219997680199E-09 |
| Normal-vs-Age(81-100Yrs) |
7.082000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.822200E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.585670E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.859400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.943600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.869200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.263200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.489200E-01 |
| Classical-VS-Follicular |
2.241400E-01 |
| Classical-VS-Other |
8.691800E-01 |
| Classical-VS-Normal |
9.26330000483588E-08 |
| Tall-VS-Follicular |
9.722400E-01 |
| Tall-VS-Other |
4.793400E-01 |
| Tall-VS-Normal |
1.83226999999064E-05 |
| Follicular-VS-Other |
5.977600E-01 |
| Follicular-VS-Normal |
1.61730000003413E-06 |
| Other-VS-Normal |
8.024200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.51550000221579E-09 |
| Normal-vs-N1 |
4.27650000000002E-05 |
| N0-vs-N1 |
5.954800E-01 |
|
|
